221 related articles for article (PubMed ID: 28423123)
1. N-acetylcysteine versus Dopamine to Prevent Acute Kidney Injury after Cardiac Surgery in Patients with Preexisting Moderate Renal Insufficiency.
Savluk OF; Guzelmeric F; Yavuz Y; Cevirme D; Gurcu E; Ogus H; Orki T; Kocak T
Braz J Cardiovasc Surg; 2017; 32(1):8-14. PubMed ID: 28423123
[TBL] [Abstract][Full Text] [Related]
2. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.
Ristikankare A; Kuitunen T; Kuitunen A; Uotila L; Vento A; Suojaranta-Ylinen R; Salmenperä M; Pöyhiä R
Br J Anaesth; 2006 Nov; 97(5):611-6. PubMed ID: 16914459
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency.
Wijeysundera DN; Beattie WS; Rao V; Granton JT; Chan CT
Can J Anaesth; 2007 Nov; 54(11):872-81. PubMed ID: 17975231
[TBL] [Abstract][Full Text] [Related]
4. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial.
Burns KE; Chu MW; Novick RJ; Fox SA; Gallo K; Martin CM; Stitt LW; Heidenheim AP; Myers ML; Moist L
JAMA; 2005 Jul; 294(3):342-50. PubMed ID: 16030279
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and non-surgical renal protective strategies for cardiac surgery patients undergoing cardiopulmonary bypass: a systematic review.
Tan SI; Brewster DJ; Horrigan D; Sarode V
ANZ J Surg; 2019 Apr; 89(4):296-302. PubMed ID: 30239089
[TBL] [Abstract][Full Text] [Related]
6. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study.
Balkanay OO; Goksedef D; Omeroglu SN; Ipek G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):209-14. PubMed ID: 25392341
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
El-Hamamsy I; Stevens LM; Carrier M; Pellerin M; Bouchard D; Demers P; Cartier R; Page P; Perrault LP
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
[TBL] [Abstract][Full Text] [Related]
9. High dose of N-acetylcystein prevents acute kidney injury in chronic kidney disease patients undergoing myocardial revascularization.
Santana-Santos E; Gowdak LH; Gaiotto FA; Puig LB; Hajjar LA; Zeferino SP; Drager LF; Shimizu MH; Bortolotto LA; De Lima JJ
Ann Thorac Surg; 2014 May; 97(5):1617-23. PubMed ID: 24657033
[TBL] [Abstract][Full Text] [Related]
10. Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass.
Song JW; Shim JK; Soh S; Jang J; Kwak YL
Nephrology (Carlton); 2015 Feb; 20(2):96-102. PubMed ID: 25384603
[TBL] [Abstract][Full Text] [Related]
11. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial.
Adabag AS; Ishani A; Koneswaran S; Johnson DJ; Kelly RF; Ward HB; McFalls EO; Bloomfield HE; Chandrashekhar Y
Am Heart J; 2008 Jun; 155(6):1143-9. PubMed ID: 18513531
[TBL] [Abstract][Full Text] [Related]
12. A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial of Aminophylline to Prevent Acute Kidney Injury in Children Following Congenital Heart Surgery With Cardiopulmonary Bypass.
Axelrod DM; Sutherland SM; Anglemyer A; Grimm PC; Roth SJ
Pediatr Crit Care Med; 2016 Feb; 17(2):135-43. PubMed ID: 26669642
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
Barr LF; Kolodner K
Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903
[TBL] [Abstract][Full Text] [Related]
14. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients.
Haase M; Haase-Fielitz A; Bagshaw SM; Reade MC; Morgera S; Seevenayagam S; Matalanis G; Buxton B; Doolan L; Bellomo R
Crit Care Med; 2007 May; 35(5):1324-31. PubMed ID: 17414730
[TBL] [Abstract][Full Text] [Related]
15. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
16. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial).
Dardashti A; Ederoth P; Algotsson L; Brondén B; Grins E; Larsson M; Nozohoor S; Zinko G; Bjursten H
Anesthesiology; 2014 Sep; 121(3):582-90. PubMed ID: 25225746
[TBL] [Abstract][Full Text] [Related]
18. Lack of effectiveness of sodium bicarbonate in preventing kidney injury in patients undergoing cardiac surgery: a randomized controlled trial.
Kristeller JL; Zavorsky GS; Prior JE; Keating DA; Brady MA; Romaldini TA; Hickman TL; Stahl RF
Pharmacotherapy; 2013 Jul; 33(7):710-7. PubMed ID: 23553549
[TBL] [Abstract][Full Text] [Related]
19. Does the prophylactic administration of N-acetylcysteine prevent acute kidney injury following cardiac surgery?
Ashworth A; Webb ST
Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):303-8. PubMed ID: 20570977
[TBL] [Abstract][Full Text] [Related]
20. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery.
Lassnigg A; Donner E; Grubhofer G; Presterl E; Druml W; Hiesmayr M
J Am Soc Nephrol; 2000 Jan; 11(1):97-104. PubMed ID: 10616845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
